These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23568978)

  • 21. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.
    Qin XL; Wang ZR; Shi JS; Lu M; Wang L; He QR
    World J Gastroenterol; 2004 Feb; 10(3):427-32. PubMed ID: 14760772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures.
    Navaneethan U; Lourdusamy V; Poptic E; Hammel JP; Sanaka MR; Parsi MA
    Dig Dis Sci; 2015 Apr; 60(4):903-9. PubMed ID: 25344422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.
    Singhi AD; Nikiforova MN; Chennat J; Papachristou GI; Khalid A; Rabinovitz M; Das R; Sarkaria S; Ayasso MS; Wald AI; Monaco SE; Nalesnik M; Ohori NP; Geller D; Tsung A; Zureikat AH; Zeh H; Marsh JW; Hogg M; Lee K; Bartlett DL; Pingpank JF; Humar A; Bahary N; Dasyam AK; Brand R; Fasanella KE; McGrath K; Slivka A
    Gut; 2020 Jan; 69(1):52-61. PubMed ID: 30971436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of the detection of serum neutrophil gelatinase-associated lipocalin in human colorectal cancer].
    Ding L; Zhang X; Zhang Y; Yang G; Liao X; Shen Z; Qiu J; Mao W; Hu L; Shao S; Shang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):589-93. PubMed ID: 24953369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Wannhoff A; Rupp C; Friedrich K; Knierim J; Flechtenmacher C; Weiss KH; Stremmel W; Gotthardt DN
    Dig Dis Sci; 2017 Feb; 62(2):510-516. PubMed ID: 27943017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic cytology in biliary strictures. Personal experience.
    Geraci G; Pisello F; Arnone E; Modica G; Sciumè C
    G Chir; 2008 Oct; 29(10):403-6. PubMed ID: 18947461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
    El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
    Pancreas; 2013 Jan; 42(1):149-54. PubMed ID: 22617715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.
    Singh S; Tang SJ; Sreenarasimhaiah J; Lara LF; Siddiqui A
    Dig Dis Sci; 2011 Aug; 56(8):2491-6. PubMed ID: 21516323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
    J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients.
    El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
    Scand J Clin Lab Invest; 2012 Dec; 72(8):602-7. PubMed ID: 23020231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
    Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness for Diagnosis of Malignancy of Bile Pyruvate Kinase M2 in Patients with Indeterminate Biliary Stricture.
    Aguilar Olivos NE; Oria-Hernández J; Briones NS; Téllez Ávila FI
    Surg Laparosc Endosc Percutan Tech; 2023 Apr; 33(2):147-151. PubMed ID: 36977323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.
    Kaur S; Chakraborty S; Baine MJ; Mallya K; Smith LM; Sasson A; Brand R; Guha S; Jain M; Wittel U; Singh SK; Batra SK
    PLoS One; 2013; 8(2):e55171. PubMed ID: 23383312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the diagnostic yield of controllable biopsy-forceps for biliary strictures.
    Inoue T; Kitano R; Kobayashi Y; Ishii N; Sakamoto K; Ohashi T; Nakade Y; Sumida Y; Ito K; Nakao H; Yoneda M
    Scand J Gastroenterol; 2018 May; 53(5):598-603. PubMed ID: 29183203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
    Zong D; Zeng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.